Fc Il-2 Mutein Fusion Protein (amg-592) Uses, Dosage, Side Effects and more
Fc Il-2 Mutein Fusion Protein (amg-592) is under investigation in clinical trial NCT03422627 (Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease).
| Attribute | Details |
|---|---|
| Trade Name | Fc Il-2 Mutein Fusion Protein (amg-592) |
| Generic | Efavaleukin alfa |
| Efavaleukin alfa Other Names | Efavaleukin alfa, Fc il-2 mutein fusion protein (amg-592), Immunoglobulin g1 (fc domain-containing fragment) fusion protein with peptide (synthetic linker) fusion protein with interleukin 2 (synthetic human mutein), dimer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
